Related Experiment Videos
[Study on mutation, expression and activity of human CD59 gene].
1Department of Immunology, Qingdao University Medical College, Qingdao 266021, China. ZZYYLL88@yahoo.com
Summary
Researchers created a human mutant CD59 (hmCD59) expression system to study its role in diabetic vascular complications. The study found hmCD59 exhibits anti-complement activity, though this is reduced after glycosylation.
Area of Science:
- Molecular Biology
- Immunology
- Diabetology
Background:
- Diabetic vascular complications represent a significant health burden.
- CD59 plays a crucial role in regulating complement-mediated damage.
- Understanding the function of mutant CD59 is vital for therapeutic development.
Purpose of the Study:
- To establish an eukaryotic expression system for human mutant CD59 (hmCD59).
- To investigate the anti-complement activity of hmCD59.
- To explore the impact of hmCD59 on diabetic vascular complications.
Main Methods:
- Construction of recombinant plasmids with hmCD59 cDNAs.
- Transfection into Chinese Hamster Ovary (CHO) cells and selection of stable clones.
- Detection of hmCD59 expression using fluorescent antibody technique, immunoenzymatic histochemistry, and Western blot.
- Assessment of anti-complement activity using BCECF/AM assay before and after glycosylation.
Main Results:
- Successfully established stable CHO cell lines expressing hmCD59 on their surface.
- Demonstrated that hmCD59 possesses anti-complement activity.
- Observed a reduction in anti-complement activity following glycosylation of hmCD59.
Conclusions:
- Two stable cell lines expressing hmCD59 were successfully developed.
- hmCD59 exhibits significant anti-complement activity.
- Glycosylation diminishes the anti-complement efficacy of hmCD59.